Cytokeratin (Pan) Antibody (Immunohistochemistry)

The Cytokeratin (Pan) Antibody is a broad-spectrum IHC marker.
It helps differentiate epithelial tumors from non-epithelial neoplasms.
In addition, cytokeratins are intermediate filament proteins expressed in epithelial cells,
supporting cellular structure and integrity.

Moreover, this antibody is a multi-epitope anti-pan-cytokeratin cocktail.
As a result, it recognizes several cytokeratin isoforms and provides consistent staining for
epithelial-derived tumors such as lung, liver, breast, and esophageal carcinomas.
Therefore, it plays a major role in routine tumor classification.

🔬 Features and Benefits

• General epithelial marker that differentiates carcinomas from sarcomas, lymphomas, and melanomas
• Clear brown cytoplasmic staining in positive cells
• Useful for tumor classification across many organ systems
• Compatible with standard IHC laboratory protocols
• Stable for up to 18 months at 2–8 °C

💡 Diagnostic Applications

• Identification of epithelial versus non-epithelial tumors
• Detection of carcinomas in multiple organs
• Research involving epithelial cell development and neoplasia
• Determining tumor origin in metastatic lesions

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the exclusive representative of
Talent Biomedical in Iran, distributes high-quality IHC antibodies including
Cytokeratin (Pan). Furthermore, the company focuses on diagnostic precision,
long-term reliability, and compliance with international standards.
As a result, pathology and molecular laboratories across Iran benefit from advanced and trusted solutions.

“Download Brochure”